DuPont Nutrition & Health announces the development of a significant new initiative with the creation of a Microbiome Venture to spearhead development of new microbiome science-based solutions.
The Microbiome Venture will play a key role in DuPont’s business growth strategy.
“Microbiome science is developing extremely fast with tremendous opportunity for innovation,” said DuPont Nutrition & Health Global Technology and Innovation Leader Angela Naef. “With the Microbiome Venture, we intend to build on our probiotics leadership position to develop new microbiome science-based solutions for health and wellness.”
For further development of product, the Microbiome Venture will involve in strategic partnerships with other microbiome science leaders in academia and industry
The Microbiome Venture is a focused entrepreneurial team with a strong connection to the larger DuPont organization, tapping into global research, development and commercialization capabilities.
The Microbiome Venture investment will complement DuPont’s existing product portfolio, especially in the areas of probiotics and prebiotics, including human milk oligosaccharides (HMOs.)
As one of the pioneers in the field of the microbiome, the APC has knowledge in microbiome science capability including an impressive track record in the areas of mother-infant and gut-brain axis.
This made them an ideal partner for DuPont Nutrition & Health’s new venture.
